Use of two unrelated umbilical cord stem cell units in stem cell transplantation for Wiskott-Aldrich syndrome

Pediatric Blood and Cancer

Volumn 47, Issue 3, 2006, Pages 332-334

  Slatter, M A ^a   Bhattacharya, A ^a   Flood, T J ^a   Abinun, M ^a   Cant, A J ^a   Gennery, A R ^a,b  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Congenital (not HIV); Cord blood; Immunodeficiency; Stem cell transplantation

Indexed keywords

BUSULFAN; CIDOFOVIR; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RIBAVIRIN; STEROID; TETANUS TOXOID; THYMOCYTE ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; BONE MARROW; CASE REPORT; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR; DOSE RESPONSE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SUBSTITUTION THERAPY; UMBILICAL CORD; VIRAL CONTAMINATION; VIRUS INFECTION; WISKOTT ALDRICH SYNDROME; X CHROMOSOME LINKED DISORDER;

CORD BLOOD STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; RISK FACTORS; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; WISKOTT-ALDRICH SYNDROME;

EID: 33746641300     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20450     Document Type: Article

References (9)

1. Dupuis-Girod S, Medioni J, Haddad E, et al. Autoimmunity in Wiskott-Aldrich syndrome: Risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 2003; 111:e622-e6227.
2. Filipovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: Collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001;97:1598-1603.
3. Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004;351:2276-2285.
4. Barker JN, Weisdorf DJ, Defor TE, et al. Transplantation of two partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105:1343-1347.
5. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: Influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100:1611-1618.
6. Knutsen AP, Steffen M, Wassmer K, et al. Umbilical cord blood transplantation in Wiskott-Aldrich Syndrome. J Pediatr 2003;142: 519-523.
7. Flomenberg P, Babbitt J, Drobyski WR, et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 1994;169:779-781.
8. Teramura T, Naya M, Yoshihara T, et al. Adenoviral infection in hematopoietic stem cell transplantation: Early diagnosis with quantitative detection of the viral genome in serum and urine. Bone Marrow Transplant 2004;33:87-92.
9. Chakrabarti S, Mautner V, Osman H, et al. Adenovirus infections following allogeneic stem cell transplantation: Incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002;100:1619-1627.